Erythromycin Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Erythromycin is an antibiotic, which is used to treat certain kind of bacterial infections. Erythromycin topical preparations are largely used on the skin to help control acne. The antibiotic is also used in combination with other medicines and are applied topically or taken orally for treating the infections. The common side effects of erythromycin include nausea, loss of appetite, diarrhea, and abdominal pain. Erythromycin prevents bacterial cells from growing and multiplying by interfering with their ability to make proteins, while not affecting human cells. It is widely used to treat chest infections such as pneumonia, skin problems such as acne and rosacea, dental abscesses, and sexually transmitted infections. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1780 Pharmaceutical manufacturers are focused on increasing access to affordable medications to provide novel options for patients and pharmacists, thereby addressing the limited availability of erythromycin tablets, which in turn is expected to augment market growth. For instance, in March, 2018, Amneal Pharmaceuticals received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg strengths. The erythromycin product is a therapeutic equivalent for the reference listed drug (RLD) erythromycin tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. Moreover, in September 2016, ANI Pharmaceuticals, Inc. launched Erythromycin Ethylsuccinate for oral suspension 200mg/5mL indicated as a treatment for various infections including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires disease, pertussis, and others. Erythromycin Market - Regional Dynamics Regional segmentation of the global erythromycin market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America erythromycin market is expected to hold a dominant position over the forecast period, owing to rising number of regulatory approvals of drugs by regulatory agencies to address the unmet medical needs of the patients and increasing prevalence of skin and soft tissue infections. For instance, in November, 2016, Rising Pharmaceuticals, Inc.—a subsidiary of Aceto Corporation— launched Erythromycin and Benzoyl Peroxide Topical Gel USP, 3-5% an FDA-approved generic version of Valeant International’s Benzamycin Gel, 3-5%. According to the Division of Infectious Diseases, Los Angeles BioMedical Research Center, 2015, skin and soft tissue infections (SSTIs) are a common reason to seek medical care in the U.S. as they can lead to complications with significant morbidity, including hospitalization, surgical procedures, or death. Report includes chapters which deeply display the following deliverable about industry : • Erythromycin Market Research Objective and Assumption • Erythromycin Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Erythromycin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Erythromycin Market, By Regions • Erythromycin Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Erythromycin Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Erythromycin Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Erythromycin Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players operating in the global erythromycin market include Ani Pharmaceuticals, Akorn, Inc., Aceto Corporation, Genesis Pharmaceuticals, Teligent, Inc., Abbvie, Inc., Abbott Laboratories, Pfizer, Inc., Sanofi-Aventis, and Allergan, Plc. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1780 Erythromycin Market Taxonomy On the basis of formulation, the global erythromycin market is segmented into: • • • • • Gel Tablet Topical Solution Ointment Others On the basis of therapeutic indications, the global erythromycin market is segmented into: • • • • • • Respiratory Tract Infections Eye Infections Ear Infections Skin and Soft Tissue Infections Gastro-intestinal Infections Others On the basis of distribution channel, the global erythromycin market is segmented into: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies On the basis of region, the global erythromycin market is segmented into: • • • • • • North America Latin America Europe Asia Pacific Middle East Africa About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
© Copyright 2024 Paperzz
